1. Population pharmacokinetics of intravenous itraconazole in patients with persistent neutropenic fever.
- Author
-
Lee, D.-G., Chae, H., Yim, D.-S., Park, S. H., Choi, S.-M., Kim, S., Choi, J.-H., Yoo, J.-H., and Shin, W.-S.
- Subjects
- *
MEDICAL research , *TREATMENT of fever , *INTRAVENOUS therapy , *PHARMACOKINETICS , *BODY weight - Abstract
Purpose: Empirical use of intravenous (IV) itraconazole (ITZ) for febrile neutropenic patients has recently been introduced in Korea. This study was designed to investigate the population pharmacokinetics (PK) of IV-ITZ. Methods: Sparse PK data were collected from febrile neutropenic patients undergoing empirical ITZ therapy at 200 mg/day after loading doses. NONMEM (Version. 5·1·1) was used to estimate population PK parameters. Results: Forty-two patients were enrolled in the study. Mean population CL and V of IV-ITZ were 10 L/h and 1050 L, respectively. Body weight was the only contributing covariate of CL. The median simulated trough concentration of ITZ after 10 days was predicted to be about 700 ng/mL. Conclusions: In this study, we explored the population PK profile of ITZ given in IV formulation. We found that the current dosage regimen of IV-ITZ (200 mg/day) was appropriate to obtain therapeutic trough concentrations for neutropenic patients in Korea. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF